Skip to main content



Local Cdiff information for Massachusetts

Massachusetts

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Massachusetts.



Local Cdiff information for Massachusetts

Massachusetts

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Massachusetts.

Providers

Dr. Alan C. Moss, MD,

FACG, FEBG
Interim Chief, Department of Gastroenterology
Boston Medical Center
725 Albany Street, 6th Floor
Boston, 02118
(617) 638-6525
EMAIL DR. MOSS >
FMT Provider: Yes
VISIT WEBSITE >

Dr. Stacy A. Kahn, MD

Director, Fecal Microbiota Transplantation; Attending Physician, Division of Gastroenterology, Hepatology and Nutrition
Boston Children’s Hospital
300 Longwood Avenue
Boston, 02115
617-355-6058
FMT Provider: Yes
VISIT WEBSITE >

Dr. Razvan Arsenescu, MD, PhD

90 Libbey Industrial Parkway
Weymouth, 02189
781-682-0630
EMAIL DR. ARSENESCU >
FMT Provider: Yes
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 2115
Hospital Onset: 2115
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.78
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: Yes
LTC Facility Data Publicly Reported: No
Law/Regulation: MGL. c .111D, s. 6
STATUTE >

State Contact

Eileen McHale
Patient Safety Ombudsman
Massachusetts Department of Public Health
Betsy Lehman Center for Patient Safety and Medical Error Reduction
99 Chauncy Street
Boston, 2111
(617) 753-7324
EMAIL EILEEN MCHALE >

CLINICAL TRIALS

Xylitol Use for Decolonization of C. Difficile in Patients With IBD

Official Title: Xylitol Use for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease
Trial No. NCT05852587
Type: Interventional
Recruitment: Not Yet Recruiting
Sponsor: Brigham and Women’s Hospital
Contact: Emma McClure
617-732-9223
EMAIL
Gender: All
Age: 18 Years and older

Outcomes and Data Collection for FMT

Official Title: Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
Trial No. NCT03562741
Type: Interventional
Recruitment: Recruiting
Sponsor: Kruna Patel, University of Massachusetts, Worcester
Contact: Anne Foley
EMAIL
Gender: All
Age: 16 years and older

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
EMAIL
Gender: All
Age: All ages

OpTION

Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
EMAIL
Gender: All
Age: 18 Years and older

ROAR

Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
EMAIL
Gender: All
Age: 18 Years and older

Pre-emptive Prevention

Official Title: A Pre-emptive Prevention Bundle for Patients at High Risk for Hospital-onset Clostridioides Difficile
Trial No. NCT058389904
Type: Interventional
Recruitment: Recruiting
Sponsor: Brigham and Women’s Hospital
Contact: Meghan A Baker, MD, SCD
617-732-8881
EMAIL
Gender: All
Age: 18 Years and older

C.Difficile Observational Study

Official Title: An Observational Study in Adults With Clostridioides Difficile Infection to Determine the Feasibility and Logistics of Biospecimen Collection, Transportation and Testing at Select US Study Sites
Trial No. NCT06277999
Type: Observational
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: AstraZeneca Clinical Study Information Center
EMAIL
Gender: All
Age: 18 Years and older

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.